+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The value of an endoprostatic coil in high risk patients with obstructive prostate cancer



The value of an endoprostatic coil in high risk patients with obstructive prostate cancer



Journal of Urology 147(4 SUPPL): 419A




(PDF emailed within 1 workday: $29.90)

Accession: 033973436

Download citation: RISBibTeXText


Related references

First-line therapy for "high-risk prostate cancer". HELP - high intensity focused ultrasound (HIFU) and Eilgard in patients with high-risk prostate cancer - a prospective, randomized study (AP 62/10 of the AUO). Der Urologe. Ausg. A 53(7): 1063-1064, 2015

Prostate Cancer in Patients With High Prostate-Specific Antigen Levels but Otherwise Very-Low-Risk Disease Behaves Like Prostate Cancer in High-Risk Patients. Clinical Genitourinary Cancer 15(4): 445-449, 2016

Treatment of advanced obstructive prostate cancer in high risk patients by insertion of a permanent metal stent. Journal of Urology 163(4 Suppl ): 159, April, 2000

The prostate cancer risk calculator from the Prostate Cancer Prevention Trial underestimates the risk of high grade cancer in contemporary referral patients. Journal of Urology 185(2): 483-487, 2011

Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients With Estimated Risk of High-grade Prostate Cancer Less Than or Equal to 10. Urology 102: 183-189, 2016

A population-based study of cancer incidence in relatives of prostate cancer patients in Finland High risk of late-onset prostate cancer and association with stomach cancer. American Journal of Human Genetics 65(4): A40, 1999

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence. Journal of Experimental & Clinical Cancer Research 32: 9-9, 2013

Performance comparison of 1.5-T endorectal coil MRI with 3.0-T nonendorectal coil MRI in patients with prostate cancer. Academic Radiology 22(4): 467-474, 2015

Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy. Bju International 99 Suppl 1: 13-6; Discussion 17-8, 2007

Role of percent positive biopsies and endorectal coil MRI in predicting prognosis in intermediate-risk prostate cancer patients. Cancer Journal From Scientific American 2(6): 343-350, 1996

Conformal radiotherapy plus high dose rate brachytherapy prostate boost in patients with intermediate and high risk prostate cancer our experience in Asian males. Journal of Radiotherapy in Practice 11(4): 257-270, 2012

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy. International Journal of Clinical Oncology 20(1): 176-181, 2015

Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE). Journal of Urology 173(5): 1557-1561, 2005

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. Bju International 110(10): E431-2; Author Reply E432, 2013